Publications by authors named "Eiko Namba"

Claim this Profile
M
Muraminomicins, novel ester derivatives: in vitro and in vivo antistaphylococcal activity.
Yoshiko Kagoshima, Akane Tokumitsu, Takeshi Masuda, Eiko Namba, Harumi Inoue

J Antibiot (Tokyo)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus.
Tarani Kanta Barman, Manoj Kumar, Tarun Mathur, Eiko Namba, Diksha Singh

Antimicrob Agents Chemother· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Antimicrobial and rapid bactericidal activities of sitafloxacin and other agents against Streptococcus pyogenes].
Eiko Namba, Ryo Okumura, Megumi Chiba, Kazuki Hoshino, Kazuhiro Tateda

Jpn J Antibiot· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption, elimination, and metabolism of CS-1036, a novel α-amylase inhibitor in rats and monkeys, and the relationship between gastrointestinal distribution and suppression of glucose absorption.
Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba

Drug Metab Dispos· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a compound that acts as a bacterial PyrG (CTP synthase) inhibitor.
Tatsuhiko Yoshida, Hatsumi Nasu, Eiko Namba, Osamu Ubukata, Makoto Yamashita

J Med Microbiol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a compound which acts as a bacterial UMP kinase PyrH inhibitor.
Tatsuhiko Yoshida, Hatsumi Nasu, Eiko Namba, Osamu Ubukata, Makoto Yamashita

FEMS Microbiol Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P₃-sparing S1P₁ agonists.
Masayoshi Asano, Tsuyoshi Nakamura, Yukiko Sekiguchi, Yumiko Mizuno, Takahiro Yamaguchi, Eiko Namba

Bioorg Med Chem Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo pharmacodynamic activity of tomopenem (formerly CS-023) against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
Kiyoshi Sugihara, Chika Sugihara, Yoko Matsushita, Naotoshi Yamamura, Mitsutoshi Uemori, Eiko Namba

Antimicrob Agents Chemother· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affinity of Tomopenem (CS-023) for penicillin-binding proteins in Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
Tetsufumi Koga, Chika Sugihara, Masayo Kakuta, Nobuhisa Masuda, Eiko Namba

Antimicrob Agents Chemother· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent in vitro activity of tomopenem (CS-023) against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Tetsufumi Koga, Nobuhisa Masuda, Masayo Kakuta, Eiko Namba, Chika Sugihara

Antimicrob Agents Chemother· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis